202 related articles for article (PubMed ID: 24122378)
1. [Validation of the IBS-SSS].
Betz C; Mannsdörfer K; Bischoff SC
Z Gastroenterol; 2013 Oct; 51(10):1171-6. PubMed ID: 24122378
[TBL] [Abstract][Full Text] [Related]
2. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
[TBL] [Abstract][Full Text] [Related]
3. Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients.
Gholamrezaei A; Zolfaghari B; Farajzadegan Z; Nemati K; Daghaghzadeh H; Tavakkoli H; Emami MH
Acta Med Iran; 2011; 49(6):390-5. PubMed ID: 21874644
[TBL] [Abstract][Full Text] [Related]
4. Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency Questionnaire.
Azpiroz F; Guyonnet D; Donazzolo Y; Gendre D; Tanguy J; Guarner F
J Clin Gastroenterol; 2015 Aug; 49(7):e64-70. PubMed ID: 25014236
[TBL] [Abstract][Full Text] [Related]
5. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
[TBL] [Abstract][Full Text] [Related]
6. Irritable bowel syndrome: a population based study.
Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
[TBL] [Abstract][Full Text] [Related]
7. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life.
Kearney DJ; McDermott K; Martinez M; Simpson TL
Aliment Pharmacol Ther; 2011 Aug; 34(3):363-73. PubMed ID: 21651595
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age.
Krogsgaard LR; Engsbro AL; Bytzer P
Scand J Gastroenterol; 2013 May; 48(5):523-9. PubMed ID: 23506174
[TBL] [Abstract][Full Text] [Related]
9. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
[TBL] [Abstract][Full Text] [Related]
11. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
Zanini B; Ricci C; Bandera F; Caselani F; Magni A; Laronga AM; Lanzini A;
Am J Gastroenterol; 2012 Jun; 107(6):891-9. PubMed ID: 22525306
[TBL] [Abstract][Full Text] [Related]
12. Validity and reliability of the Malay-language translation of the Rome III Diagnostic Questionnaire for irritable bowel syndrome.
Lee YY; Waid A; Tan HJ; Chua SB; Whitehead WE
J Gastroenterol Hepatol; 2012 Apr; 27(4):746-50. PubMed ID: 22004172
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
[TBL] [Abstract][Full Text] [Related]
14. Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome.
Portincasa P; Bonfrate L; Scribano ML; Kohn A; Caporaso N; Festi D; Campanale MC; Di Rienzo T; Guarino M; Taddia M; Fogli MV; Grimaldi M; Gasbarrini A
J Gastrointestin Liver Dis; 2016 Jun; 25(2):151-7. PubMed ID: 27308645
[TBL] [Abstract][Full Text] [Related]
15. The Short Health Scale: A Simple, Valid, Reliable, and Responsive Way of Measuring Subjective Health in Patients With Irritable Bowel Syndrome.
Krarup AL; Peterson E; Ringström G; Törnblom H; Hjortswang H; Simrén M
J Clin Gastroenterol; 2015 Aug; 49(7):565-70. PubMed ID: 25216385
[TBL] [Abstract][Full Text] [Related]
16. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
Corsetti M; Caenepeel P; Fischler B; Janssens J; Tack J
Am J Gastroenterol; 2004 Jun; 99(6):1152-9. PubMed ID: 15180740
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of celiac disease among pediatric patients with irritable bowel syndrome: a 6-year prospective cohort study.
Cristofori F; Fontana C; Magistà A; Capriati T; Indrio F; Castellaneta S; Cavallo L; Francavilla R
JAMA Pediatr; 2014 Jun; 168(6):555-60. PubMed ID: 24756157
[TBL] [Abstract][Full Text] [Related]
18. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
[TBL] [Abstract][Full Text] [Related]
19. Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome.
Mazzawi T; Hausken T; Gundersen D; El-Salhy M
Mol Med Rep; 2013 Sep; 8(3):845-52. PubMed ID: 23820783
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of irritable bowel syndrome in medical outpatients in Japan.
Shinozaki M; Fukudo S; Hongo M; Shimosegawa T; Sasaki D; Matsueda K; Harasawa S; Miura S; Mine T; Kaneko H; Arakawa T; Haruma K; Torii A; Azuma T; Miwa H; Fukunaga M; Handa M; Kitamori S; Miwa T;
J Clin Gastroenterol; 2008 Oct; 42(9):1010-6. PubMed ID: 18607295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
